3 healthcare shares that I want in my portfolio

CSL Limited (ASX:CSL) shares are one of three that I think investors ought to consider buying in the healthcare sector…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

One area of the market that I'm especially bullish on over the long-term is the healthcare sector.

I believe this area of the market is well positioned to grow strongly over the next decade or two due to growing demand for healthcare services and the emergence of new technologies.

Three healthcare shares that I think could make great long-term investments are as follows:

CSL Limited (ASX: CSL)

CSL Limited is one of the world's leading biopharmaceutical companies. Over the last decade the company has consistently grown its sales and earnings at a strong rate thanks to its core business and ever-expanding portfolio of lucrative products. I don't expect this to change any time soon and believe it would be a fantastic share to buy and hold.

ResMed Inc. (ASX: RMD)

Another top option in the healthcare sector in my opinion is ResMed. It is a medical device company with a focus on the sleep treatment market. Like CSL, it has a long track record of generating solid earnings growth and creating wealth for its shareholders. Pleasingly, due to its leading products, wide distribution, and growing market, I believe the company is well-positioned to continue this trend for a long time to come.

Volpara Health Technologies Ltd (ASX: VHT)

Volpara Health Technologies has been growing at an explosive rate over the last 18 months thanks to its popular breast imaging analytics and analysis software. In its recent half year results management advised that 5.4% of women being screened (2.1 million) in the United States are now being actively analysed by a Volpara product. This is expected to grow to 9% by the end of the financial year. Importantly, with much of its breast imaging analytics data flowing to the cloud, the company now has one of the biggest cross-vendor data sets in mammography. Management believes this is a powerful asset not only for finding key insights to help detect breast cancer early but also for developing new products that can help increase its average price per patient.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended VOLPARA FPO NZ. The Motley Fool Australia has recommended ResMed Inc. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

a man in a business suit points his finger amid a digitised map of the globe suspended in the air in front of him, complete with graphs, digital code and glyphs to indicate digital assets.
Investing Strategies

Future focus: How to diversify your portfolio with ASX AI ETFs

Looking for a simple and effective way to capitalise on the growth of AI technologies across global markets?

Read more »

chart showing an increasing share price
Growth Shares

Buy these excellent ASX growth shares for 15% to 20% returns

Analysts think big returns could be on the cards for owners of these shares.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Growth Shares

These ASX 200 growth shares could rise 12% to 30%

Analysts think big returns could be on offer from these shares.

Read more »

Man in an office celebrates at he crosses a finish line before his colleagues.
Growth Shares

Hoping to beat the ASX 200? I'd consider buying these 3 ASX shares

Analysts think these shares can outperform the market.

Read more »

a happy investor with a wide smile points to a graph that shows an upward trending share price
Growth Shares

5 top ASX growth shares to buy in April

Analysts think growth investors should be buying these shares.

Read more »

A young woman holds her hand to her mouth in surprise as she reads something on her laptop.
Growth Shares

These mid-cap ASX shares could rise 20% to 50%

Goldman Sachs is tipping these stocks as buys.

Read more »

A happy boy with his dad dabs like a hero while his father checks his phone.
Growth Shares

2 ASX growth shares that could turn $1,000 into $10,000 by 2034

I think these two stocks have a shot at being 10-baggers.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Growth Shares

These top ASX 200 growth shares can rise 10% to 50%

Analysts see major upside ahead for these buy-rated shares.

Read more »